Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Drug Discovery And Development

Cancer Research UK announces drug discovery collaboration with Celgene Corporation

Cancer Research UK announces the signing of a five-year drug-discovery collaboration between its subsidiary, Cancer Research Technology, and Celgene Corporation

Experimental drug trial seeks to improve treatment for head and neck cancer

A trial to test an experimental drug in patients with head and neck cancer launches in the UK through the Combinations Alliance.

Scientists exploit leaks in blood brain barrier to treat glioblastoma

An ovarian cancer drug can leak through the blood brain barrier to reach brain tumours and could be an effective treatment for glioblastoma.

Cancer Research UK launches trial to test new drug in patients with advanced cancer

A clinical trial to test a new cancer drug in patients with advanced solid tumours, launches in four centres across the UK today.

New bladder cancer therapy to start clinical trials

An experimental treatment for bladder cancer will move into an early phase clinical trial under an agreement signed today.

Hitgen and Cancer Research UK’s Manchester Institute enter licence agreement in lung cancer

Cancer Research UK, Cancer Research Technology and HitGen Ltd have entered into a licence agreement to develop a novel class of drugs in lung cancer.

Cancer Research Technology, UCL, and Tusk Therapeutics join forces to develop cancer immunotherapies

Cancer Research Technology, Tusk Therapeutics and UCL have signed an agreement to research, develop and commercialise an antibody-based therapeutic.

Cancer Research Technology pioneer fund announces investment in blood cancer drugs

The Cancer Research Technology (CRT) Pioneer Fund announced an investment to develop a promising new class of drugs for blood cancer.

CRT and University of Manchester receive success payment from GlaxoSmithKline for cancer epigenetics research collaboration

Cancer Research Technology (CRT) has today received a success payment from GlaxoSmithKline resulting from its research collaboration.

CRT and SV Life Sciences form Artios Pharma to focus on DNA damage response

Cancer Research Technology (CRT) and SV Life Sciences have today announced the launch of Artios Pharma.

Pages